Clinical Trial Update: A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is underway to evaluate WD-890 for moderate-to-severe plaque psoriasis, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• WD-890

Snippet

Sponsor: Zhejiang Wenda Pharma Technology LTD. | Conditions: Brief Description of Focus of Study | Phase 2 | Status: RECRUITING